Highland Capital Management LLC lessened its holdings in Koninklijke Philips (NYSE:PHG – Free Report) by 2.3% during the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor owned 80,285 shares of the technology company’s stock after selling 1,921 shares during the period. Highland Capital Management LLC’s holdings in Koninklijke Philips were worth $2,033,000 as of its most recent SEC filing.
Other large investors also recently added to or reduced their stakes in the company. Wilmington Savings Fund Society FSB purchased a new position in shares of Koninklijke Philips during the third quarter worth about $54,000. Eastern Bank bought a new stake in Koninklijke Philips during the third quarter valued at approximately $88,000. RPg Family Wealth Advisory LLC bought a new stake in Koninklijke Philips during the third quarter valued at approximately $107,000. OLD National Bancorp IN purchased a new position in Koninklijke Philips in the 3rd quarter worth approximately $202,000. Finally, Cable Hill Partners LLC purchased a new stake in shares of Koninklijke Philips during the 3rd quarter valued at $203,000. Institutional investors own 13.67% of the company’s stock.
Koninklijke Philips Stock Up 2.9 %
PHG opened at $28.07 on Friday. The company has a debt-to-equity ratio of 0.60, a quick ratio of 0.74 and a current ratio of 1.16. Koninklijke Philips has a 1 year low of $19.55 and a 1 year high of $32.91. The stock’s 50 day simple moving average is $25.97 and its 200 day simple moving average is $28.09.
Analyst Upgrades and Downgrades
Check Out Our Latest Report on Koninklijke Philips
Koninklijke Philips Company Profile
Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. The company operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. It also provides diagnostic imaging solutions, includes magnetic resonance imaging, X-ray systems, and computed tomography (CT) systems and software comprising detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; integrated interventional systems, and interventional diagnostic and therapeutic devices to treat coronary artery and peripheral vascular disease.
Read More
- Five stocks we like better than Koninklijke Philips
- How to Invest in Biotech Stocks
- How Growth Investors Find High-Growth Stocks and Maximize Returns
- How to Invest in Insurance Companies: A Guide
- Meta’s AI & Smart Glasses Could Drive 20%+ Upside in 2025
- 3 Small Caps With Big Return Potential
- NVIDIA’s Slide Continues: Can Retail Investors Stop the Fall?
Receive News & Ratings for Koninklijke Philips Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Koninklijke Philips and related companies with MarketBeat.com's FREE daily email newsletter.